The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...
Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could become the first shot of its type to be cleared ...
Indian vaccine makers, Bharat Biotech and Zydus Cadila, must publish studies on the efficacy of their vaccines in relation to the Omicron variant. ZY-19489 is a potential single dose radical cure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback